Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Behavior Modification|November 28, 2015
Validity and Reliability of GraphClick and DataThief III for Data ExtractionAndrea Flower, John William McKenna, Gita Upreti
Children and Youth Services Review|May 23, 2017
Behavior problems and children's academic achievement: A test of growth-curve models with gender and racial differencesKristen P Kremer, Andrea Flower, Jin Huang, et al.
Behavior Modification|October 18, 2013
Effects of the Good Behavior Game on classwide off-task behavior in a high school basic algebra resource classroomAndrea Flower, John McKenna, Colin S Muething, et al.
Journal of the American Heart Association|February 14, 2019
Relationship Between Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With EvolocumabMichael D Shapiro, Jessica Minnier, Hagai Tavori, et al.
Dermatology and Therapy|May 14, 2023
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT SurveyJoseph F Merola, Alexis Ogdie, Alice B Gottlieb, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 27, 2022
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trialUlrich Mrowietz, Jonathan Barker, Curdin Conrad, et al.
Cardiovascular Drugs and Therapy|August 4, 2018
Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension StudiesLeslie Cho, Ricardo Dent, Erik S G Stroes, et al.
American Journal of Clinical Dermatology|June 14, 2023
Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet's SyndromePhilip J Mease, Gülen Hatemi, Maria Paris, et al.
Pageof 1